Bolt Biotherapeutics pivots to Prana’s Phase 2 asset as $120 million private placement funds runway into 2028
Market Chameleon (Mon, 26-Oct 11:22 AM)
Bolt Biotherapeutics rallies after Prana acquisition and $120 million private placement repositions the company around PRA-216 Phase 2 readouts
Market Chameleon (Fri, 23-Oct 10:25 AM)
